cdmo.directory
← Compare landing

重庆兴泰濠制药有限公司 (Sintaho) vs Yongtai Technology

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

Category重庆兴泰濠制药有限公司 (Sintaho)Yongtai Technology
SummaryChina-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
Modalities
  • Small Molecule
  • Peptide
Data not yet provided.
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • HPAPI
Data not yet provided.
Locations
  • Headquarters, Chongqing, Chongqing, China
  • Headquarters, Linhai, Zhejiang, China
Certifications
  • Internet Drug Information Service Qualification (Chongqing) · Identifier: (渝)-非经营性-2022-0020
Data not yet provided.

Find similar companies

重庆兴泰濠制药有限公司 (Sintaho) alternatives · Yongtai Technology alternatives

Markdown mirror: /compare/sintaho/yongtaitech.md